VCAM1 and COVID-19: Further validation in human samples from patients hospitalized with COVID-19 infection showed that circulating endothelial injury markers VCAM-1 and E-Selectin were concordantly impacted with higher expression in men diagnosed with COVID-19, as compared to women.